Pak Fah Yeow International Limited
Research Pak Fah Yeow International Limited (0239.HK) on Bullrun: market cap HKD 744.82M, P/E 7.5, dividend yield 8.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0239.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 744.82M
- P/E7.5
- Dividend yield8.4%
- Financial periodFY2025
- RevenueHKD 214.02M
- Revenue growth-9.7%
- Net incomeHKD 91.35M
- Free cash flowHKD 112.33M
- Gross margin86.3%
Valuation Snapshot
latest market cap is HKD 744.82M; P/E is 7.5; dividend yield is 8.4%.
Peer valuation comparison
Latest P/E is 7.47x versus a Healthcare sector median of 21.74x (65.7% below).
Latest dividend yield is 8.37% versus a Healthcare sector median of 2.4% (248.7% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | HKD 214.02M | HKD 91.35M | HKD 112.33M | 86.3% | n/a | HKD 331.27M | HKD 4.79M | HKD 722.75M |
| FY2024 | HKD 236.92M | HKD 78.63M | HKD 78.02M | 86.2% | 0.25 | HKD 275.82M | HKD 4.20M | HKD 731.91M |
| FY2023 | HKD 259.31M | HKD 105.04M | HKD 144.84M | 84.5% | 0.34 | HKD 265.51M | HKD 4.74M | HKD 765.18M |
| FY2022 | HKD 147.33M | HKD 29.96M | HKD 39.76M | 78.9% | 0.1 | HKD 169.44M | HKD 5.50M | HKD 707.23M |
| FY2021 | n/a | n/a | n/a | n/a | 0.12 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 744.82M | 7.5 | 2.9% | 0.07 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.07 HKD, yield 8.4%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.19 HKD |
| FY2024 | 0.22 HKD |
| FY2023 | 0.15 HKD |
| FY2022 | 0.08 HKD |
| FY2021 | 0.07 HKD |
About Pak Fah Yeow International Limited
Pak Fah Yeow International Limited, an investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name. The company operates through three segments: Healthcare, Property Investments, and Treasury Investments. It offers White Flower Embrocation medicated oils, strain relief products, and ointments, as well as Fúzai 239, a floral-scented White Flower Embrocation. The company also invests in commercial, industrial, residential, and car park properties;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Pak Fah Yeow International Limited's market cap?
Pak Fah Yeow International Limited's market capitalization is HKD 744.82M.
What is Pak Fah Yeow International Limited's P/E ratio?
Pak Fah Yeow International Limited's price-to-earnings (P/E) ratio is 7.5.
Does Pak Fah Yeow International Limited pay a dividend?
Pak Fah Yeow International Limited has a dividend yield of 8.4%.
What does Pak Fah Yeow International Limited do?
Pak Fah Yeow International Limited, an investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name. The company operates through three segments: Healthcare, Property Investments, and Treasury Investments. It offers White Flower Embrocation medicated oils, strain relief products, and ointments, as well as Fúzai 239, a floral-scented White Flower Embrocation.